跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,693 条关于
“refractory membranous nephropathy”
全部
17,693
临床试验
14,942
药物
89
机构
14
资讯
2,648
3个月前
Obinutuzumab Demonstrates 86% Overall Remission in Refractory Membranous Nephropathy: First Single-Arm Meta-Analysis
去年
Excyte Doses First Patient with YK012, World's First T Cell Engager for Primary Membranous Nephropathy
去年
Everest Medicines Reports Promising Phase 1b/2a Results for EVER001 BTK Inhibitor in Primary Membranous Nephropathy
去年
Everest Medicines' EVER001 Shows Promise in Phase 1b/2a Trial for Primary Membranous Nephropathy
去年
Vertex and Ono Pharmaceutical Form Strategic Alliance for Povetacicept Development in Japan and South Korea
5个月前
Biogen Acquires Global Rights to Felzartamab with $850 Million Deal for Greater China Assets
8个月前
Climb Bio Advances Multi-Drug Pipeline with Phase 2 Trial Initiation and 2026 Data Readouts Expected
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
10个月前
Kidney Week 2025 Showcases Breakthrough Therapies Across Nephrology with Eight Major Trial Updates
去年
Hydroxychloroquine Shows Promise for Kidney Protection in Primary Glomerular Disease and Lupus Nephritis
第 1 页，共 265 页
上一页
下一页
